Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy.

Pelin, Adrian; Foloppe, Johann; Petryk, Julia; Singaravelu, Ragunath; Hussein, Marian; Gossart, Florian; Jennings, Victoria A; Stubbert, Lawton J; Foster, Madison; Storbeck, Christopher; Postigo, Antonio; Scut, Elena; Laight, Brian; Way, Michael; Erbs, Philippe; Le Boeuf, Fabrice; Bell, John C

Pelin, Adrian; Foloppe, Johann; Petryk, Julia; Singaravelu, Ragunath; Hussein, Marian; Gossart, Florian; Jennings, Victoria A; Stubbert, Lawton J; Foster, Madison; Storbeck, Christopher; Postigo, Antonio; Scut, Elena; Laight, Brian; Way, Michael; Erbs, Philippe; Le Boeuf, Fabrice; Bell, John C.

Afiliação

Pelin A; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Foloppe J; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Petryk J; Transgene S.A., 400 Boulevard Gonthier d'Andernach, 67405 Illkirch-Graffenstaden, France.
Singaravelu R; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Hussein M; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Gossart F; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Jennings VA; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Stubbert LJ; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Foster M; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Storbeck C; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Postigo A; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Scut E; Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, England, UK.
Laight B; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Way M; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Erbs P; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Le Boeuf F; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Bell JC; Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, England, UK.

Mol Ther Oncolytics ; 14: 246-252, 2019 Sep 27.

Article em En | MEDLINE | ID: mdl-31428674

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google